433241-66-8 Usage
Uses
Used in Pharmaceutical Industry:
N1-(2-hydroxypropyl)-N2-(3-(trifluoromethyl)phenyl)oxalamide is used as a potential drug candidate for its possible biological activity, which may include therapeutic effects against various diseases or conditions. Its specific application would depend on the results of further research into its pharmacological properties.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, N1-(2-hydroxypropyl)-N2-(3-(trifluoromethyl)phenyl)oxalamide serves as a chemical intermediate. It can be utilized in the synthesis of other compounds with potential medicinal applications, contributing to the discovery of new drugs and therapeutic agents.
Used in Organic Chemistry Research:
N1-(2-hydroxypropyl)-N2-(3-(trifluoromethyl)phenyl)oxalamide is also used as a subject of study in organic chemistry. Its unique structure and properties make it an interesting compound for exploring new reactions, mechanisms, and the development of novel synthetic methods. This research can lead to advancements in the understanding of chemical behavior and the creation of new chemical entities with various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 433241-66-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,3,2,4 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 433241-66:
(8*4)+(7*3)+(6*3)+(5*2)+(4*4)+(3*1)+(2*6)+(1*6)=118
118 % 10 = 8
So 433241-66-8 is a valid CAS Registry Number.
433241-66-8Relevant academic research and scientific papers
Novel Crystalline Form
-
, (2011/10/04)
Crystalline Forms of 6-[2-(4-cyano-phenyl)-2H-pyrazol-3-yl]-5-methyl-3-oxo-4-(3-trifluoromethyl-phenyl)-3,4-dihydro-pyrazine-2-carboxylic acid ethylamide are disclosed together with processes for preparing the Forms, pharmaceutical compositions comprising
2-PYRAZINONE DERIVATIVES AND THEIR USE AS INHIBITORS OF NEUTROPHILE ELASTASE
-
Page/Page column 50, (2009/06/27)
The invention provides compounds of formula (I) wherein R1, R3, R4, R5, R14, X and W are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceut
SOME 2-PYRAZINONE DERIVATIVES AND THEIR USE AS INHIBITORS OF NEUTROPHILE ELASTASE
-
Page/Page column 41-42; 55, (2009/06/27)
The invention provides certain novel 6-heteroaryl-5-methyl-3- oxo-4- [3 (trif luoromethyl) phenyl] -3,4-dihydropyrazine-2- carboxamide derivatives and pharmaceutically acceptable salts thereof and particular Forms thereof; together with processes for thei
2-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF DISEASE OR CONDITION IN WHICH INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY IS BENEFICIAL.
-
Page/Page column 54, (2008/06/13)
The invention provides compounds of formula (I) wherein R1, R3, R4, R5, R14, X and W are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acce
